{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/eli-lilly-and-company/","json":"https://alysly.com/json/markets/stocks/eli-lilly-and-company/index.json","lang":"en-US","title":"Eli Lilly and Company (LLY) Stock Price Today | US5324571083","description":"Eli Lilly and Company (LLY). Revenue $65.2bn, net margin 31.7% (FY ended Dec 2025). ISIN US5324571083 · WKN 858560.","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/eli-lilly-and-company/","json":"https://alysly.com/json/de/maerkte/aktien/eli-lilly-and-company/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Eli Lilly and Company","url":"https://alysly.com/markets/stocks/eli-lilly-and-company/"}],"content":[{"type":"heading","level":1,"text":"Eli Lilly and Company (LLY)"},{"type":"paragraph","text":"LLY · Health Care · United States","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"United States","href":"https://alysly.com/markets/stocks/browse/?country=United%20States"}]},{"type":"paragraph","text":"Eli Lilly and Company (LLY) is a US company in the Health Care sector. Eli Lilly develops and sells prescription medicines. Its fastest-growing products in recent years have been the diabetes and weight-loss treatments Mounjaro and Zepbound, both based on the active ingredient tirzepatide. Other areas include oncology, immunology and neuroscience, where the Alzheimer's treatment Kisunla received US approval in 2024. Lilly was founded in 1876 and is based in Indianapolis, Indiana."},{"type":"paragraph","text":"The stock has its largest weight in XUHL (MSCI USA Health Care), at 16.40%. Anyone who holds an ETF containing Eli Lilly and Company also has an indirect stake in the company."},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Eli Lilly and Company"},{"type":"heading","level":3,"text":"Key Data for Eli Lilly and Company"},{"type":"facts","items":[{"label":"Held in","value":"22 ETFs"},{"label":"Highest weight","value":"16.40%"},{"label":"Indices","value":"11"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"United States"},{"label":"ISIN","value":"US5324571083"},{"label":"WKN","value":"858560"}]},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"Eli Lilly and Company Stock Price Chart"},{"type":"paragraph","text":"The Eli Lilly and Company chart shows daily closing prices and is set to the current year by default. The stock is up 31.9% year to date and up 67.9% over twelve months. The last recorded close on October 30, 2026, was $1,417.54, at 100% of the 52-week range."},{"type":"paragraph","text":"Price series from our database since Jul 11, 2024, 580 daily values."},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"heading","level":3,"text":"Eli Lilly and Company Stock Performance"},{"type":"table","caption":"Eli Lilly and Company stock performance","rows":[["Year to date","+31.9%","1 year","+67.9%"],["1 month","+22.5%","3 months","+23.4%"],["Calendar year 2025","+39.2%","",""]]},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"paragraph","text":"Measured in euros, Eli Lilly and Company is up 38.7% year to date and up 73.5% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Eli Lilly and Company"},{"type":"heading","level":3,"text":"What ETF Is Eli Lilly and Company In?"},{"type":"paragraph","text":"Eli Lilly and Company has above-average ETF coverage and is held by 22 of the 104 ETFs we track, which together follow 11 indices. That puts the stock in more ETFs than 85.1% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"table","caption":"What ETF is Eli Lilly and Company in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"XUHL / XUHC","links":[{"text":"XUHL","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-health-care-ucits-etf-1c/"}]},{"text":"MSCI USA Health Care","href":"https://alysly.com/markets/indices/msci-usa-health-care/"},"16.40%","€163.97"],[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"12.14%","€121.37"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"12.12%","€121.23"],[{"text":"XDEQ","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-quality-ucits-etf-1c/"},{"text":"MSCI World Quality","href":"https://alysly.com/markets/indices/msci-world-quality/"},"2.94%","€29.36"],[{"text":"SXR8","href":"https://alysly.com/markets/etfs/ishares-core-sp-500-ucits-etf-acc/"},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"1.74%","€17.40"],[{"text":"SPYL / SPY5","links":[{"text":"SPYL","href":"https://alysly.com/markets/etfs/state-street-spdr-sp-500-ucits-etf-acc/"}]},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"1.65%","€16.52"],[{"text":"XD9U / XD9D","links":[{"text":"XD9U","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-ucits-etf-1c/"}]},{"text":"MSCI USA","href":"https://alysly.com/markets/indices/msci-usa/"},"1.65%","€16.48"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"1.26%","€12.60"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"1.21%","€12.11"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"1.21%","€12.11"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"1.21%","€12.06"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"1.12%","€11.20"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"1.08%","€10.80"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"1.08%","€10.75"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.94%","€9.38"],[{"text":"XDEB","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-minimum-volatility-ucits-etf-1c/"},{"text":"MSCI World Minimum Volatility","href":"https://alysly.com/markets/indices/msci-world-minimum-volatility/"},"0.40%","€4.02"],[{"text":"XDEW","href":"https://alysly.com/markets/etfs/xtrackers-sp-500-equal-weight-ucits-etf-1c/"},{"text":"S&P 500 Equal Weight","href":"https://alysly.com/markets/indices/sp500-equal-weight/"},"0.24%","€2.38"]]},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Eli Lilly and Company, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Eli Lilly and Company (weight per latest SEC filing): VUG 2.81%, IVV 1.47%, SPY 1.47%, VOO 1.47%, VTI 1.40%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"VUG","href":"https://alysly.com/markets/etfs/us/vug/"},{"text":"IVV","href":"https://alysly.com/markets/etfs/us/ivv/"},{"text":"SPY","href":"https://alysly.com/markets/etfs/us/spy/"},{"text":"VOO","href":"https://alysly.com/markets/etfs/us/voo/"},{"text":"VTI","href":"https://alysly.com/markets/etfs/us/vti/"}]},{"type":"list","ordered":false,"items":[{"text":"Eli Lilly and Company among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 22 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Eli Lilly and Company Weight in iShares Core MSCI World (EUNL) Since 2019"},{"type":"image","alt":"Eli Lilly and Company: weight in EUNL 0.24% → 1.26%"},{"type":"paragraph","text":"Sep 30, 2019 Oct 30, 2026"},{"type":"paragraph","text":"In iShares Core MSCI World (EUNL), Eli Lilly and Company had a weight of 0.24% on Sep 30, 2019 and 1.26% on Oct 30, 2026. The fund tracks the MSCI World. That is also the stock's highest weight in the period shown. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core MSCI World (EUNL)","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"}]},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Eli Lilly and Company overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Which Tracked Investors Hold Eli Lilly and Company?"},{"type":"paragraph","text":"Eli Lilly and Company is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 3 tracked managers holding the stock, 1 added and 1 cut.","links":[{"text":"GOOGL","href":"https://alysly.com/markets/stocks/alphabet-inc-class-a/"}]},{"type":"table","caption":"Tracked investors holding this stock","columns":["Investor","Shares","Value","Quarter"],"rows":[["Bridgewater Associates","87,023","$104M","increased by 16,211"],["Soros Fund Management","22,199","$27M","unchanged"],["Duquesne Family Office","12,380","$15M","reduced by 88,295"]]},{"type":"paragraph","text":"As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Eli Lilly and Company"},{"type":"table","caption":"Stocks with ETF exposure similar to Eli Lilly and Company","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["Eli Lilly and Company","–","–","+67.9%","38.0%","31.7%","+44.7%"],[{"text":"McKesson Corporation","href":"https://alysly.com/markets/stocks/mckesson-corporation/"},"21","–","+20.5%","28.4%","1.2%","+12.4%"],[{"text":"ResMed","href":"https://alysly.com/markets/stocks/resmed-inc/"},"21","–","-8.8%","28.8%","26.9%","+9.9%"],[{"text":"Edwards Lifesciences Corporation","href":"https://alysly.com/markets/stocks/edwards-lifesciences-corporation/"},"21","–","+10.2%","25.0%","17.7%","+11.5%"],[{"text":"HCA Healthcare Inc","href":"https://alysly.com/markets/stocks/hca-healthcare-inc/"},"21","–","+1.4%","29.0%","9.0%","+7.1%"],[{"text":"AbbVie","href":"https://alysly.com/markets/stocks/abbvie-inc/"},"21","+0.65","+29.2%","26.5%","6.9%","+8.6%"],[{"text":"Abbott Laboratories","href":"https://alysly.com/markets/stocks/abbott-laboratories/"},"21","–","-14.8%","24.0%","14.7%","+5.7%"],[{"text":"Cardinal Health","href":"https://alysly.com/markets/stocks/cardinal-health-inc/"},"21","–","+31.9%","26.3%","0.7%","+14.2%"],[{"text":"Cencora","href":"https://alysly.com/markets/stocks/cencora-inc/"},"21","–","-3.0%","26.1%","0.5%","+9.3%"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Eli Lilly and Company. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Eli Lilly and Company"},{"type":"heading","level":3,"text":"Eli Lilly and Company Key Financials"},{"type":"facts","items":[{"label":"Revenue","value":"$65.2B"},{"label":"Net income","value":"$20.6B"},{"label":"Diluted EPS","value":"$22.95"},{"label":"Net margin","value":"31.7%"},{"label":"Return on equity","value":"77.8%"},{"label":"Equity ratio","value":"23.6%"},{"label":"Revenue growth","value":"+44.7%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","34.1","5.2","15.4%"],["FY ended Dec 2024","45.0","10.6","23.5%"],["FY ended Dec 2025","65.2","20.6","31.7%"]]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"heading","level":3,"id":"patents","text":"Latest Patents Granted to Eli Lilly"},{"type":"paragraph","text":"In the 52 weekly issues of the US patent office from Nov 4, 2025 to Oct 27, 2026, Eli Lilly received 69 utility patents and 16 design patents. That is 0.022% of all utility patents the US patent office granted in those weeks. The median time from filing to grant was 4.4 years."},{"type":"table","caption":"The five most recent utility patents granted to Eli Lilly","columns":["Granted","Patent","Title","Filed","Technology field"],"rows":[["Oct 20, 2026","US 12770737 B2","Physiological data monitoring system","Aug 18, 2021","G16H Healthcare informatics"],["Oct 20, 2026","US 12767714 B2","LAG-3 and PD-1/LAG-3-antibodies","Nov 17, 2023","C07K Chemistry; metallurgy"],["Sep 22, 2026","US 12741999 B2","Incretin analogs and uses thereof","Oct 30, 2023","C07K Chemistry; metallurgy"],["Sep 15, 2026","US 12735433 B2","Macrocyclic glucagon-like peptide 1 receptor agonists","May 19, 2022","C07D Chemistry; metallurgy"],["Sep 1, 2026","US 12723063 B2","GIPR-agonist compounds","Dec 20, 2023","C07K Chemistry; metallurgy"]]},{"type":"paragraph","text":"These are grants, not applications. The office usually publishes an application 18 months after the priority date; the grant tends to come much later. Owners counted: Eli Lilly and Company. Titles as published by the office; median time based on 37 patents with a known filing date."},{"type":"paragraph","text":"The patent screener lists more grants, filterable by company, type and technology field. The M&A and patents page compares companies.","links":[{"text":"patent screener","href":"https://alysly.com/tools/patent-screener/#c=eli-lilly-and-company"},{"text":"M&A and patents","href":"https://alysly.com/m-and-a/"}]},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: Eli Lilly and Company"},{"type":"heading","level":3,"text":"Eli Lilly and Company Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-34.8%"},{"label":"Annualized volatility","value":"38.0%"}]},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"facts","items":[{"label":"Below peak","value":"0.0%"},{"label":"Beta to S&P 500","value":"0.19"},{"label":"Correlation to S&P 500","value":"0.07"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was the highest since our series began on Jul 11, 2024. When the S&P 500 rose or fell 1%, Eli Lilly and Company moved 0.19% on average in the same direction (past 252 trading days). The correlation of 0.07, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Eli Lilly and Company."},{"type":"paragraph","text":"Data note 14","href":"#dn-14"},{"type":"heading","level":3,"text":"What Eli Lilly and Company Correlates With"},{"type":"table","caption":"What Eli Lilly and Company Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"Astrazeneca plc","href":"https://alysly.com/markets/stocks/astrazeneca-plc/"},"+0.67",""],[{"text":"Johnson & Johnson","href":"https://alysly.com/markets/stocks/johnson-johnson/"},"+0.66",""],[{"text":"AbbVie Inc.","href":"https://alysly.com/markets/stocks/abbvie-inc/"},"+0.65",""],[{"text":"Pfizer Inc.","href":"https://alysly.com/markets/stocks/pfizer-inc/"},"+0.63",""],[{"text":"Royalty Pharma Plc Class A","href":"https://alysly.com/markets/stocks/royalty-pharma-plc-class-a/"},"+0.63",""],[{"text":"Vertex Pharmaceuticals Incorporated","href":"https://alysly.com/markets/stocks/vertex-pharmaceuticals-incorporated/"},"+0.62",""],[{"text":"Keysight Technologies Inc","href":"https://alysly.com/markets/stocks/keysight-technologies-inc/"},"-0.53",""],[{"text":"Qnity Electronics Inc.","href":"https://alysly.com/markets/stocks/qnity-electronics-inc/"},"-0.48",""],[{"text":"Texas Instruments Incorporated","href":"https://alysly.com/markets/stocks/texas-instrument-inc/"},"-0.48",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 15","href":"#dn-15"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Eli Lilly and Company"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Profile based on public company information, mainly annual reports and required SEC filings (Form 10-K or 20-F). · As of 2026-09"},{"id":"dn-2","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-3","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-4","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-5","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-6","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-7","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-8","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-9","text":"Holdings as of quarter end from the mandatory filings (Form 13F) with the US securities regulator; the deadline runs up to 45 days."},{"id":"dn-10","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-11","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-12","text":"Grants by the US patent office from its weekly publications (public domain, source: USPTO), counted by the owner at the time of grant."},{"id":"dn-13","text":"Computed from the full available price history."},{"id":"dn-14","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-15","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/eli-lilly-and-company/#webpage","url":"https://alysly.com/markets/stocks/eli-lilly-and-company/","name":"Eli Lilly and Company – Alysly","description":"Eli Lilly and Company (LLY). Revenue $65.2bn, net margin 31.7% (FY ended Dec 2025). ISIN US5324571083 · WKN 858560.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/eli-lilly-and-company/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Eli Lilly and Company"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/eli-lilly-and-company/#entity","name":"Eli Lilly and Company","tickerSymbol":"LLY","url":"https://alysly.com/markets/stocks/eli-lilly-and-company/","mainEntityOfPage":"https://alysly.com/markets/stocks/eli-lilly-and-company/","description":"Eli Lilly and Company (LLY). Revenue $65.2bn, net margin 31.7% (FY ended Dec 2025). ISIN US5324571083 · WKN 858560.","logo":"https://alysly.com/stock-logos/eli-lilly-and-company-logo.webp","image":"https://alysly.com/stock-logos/eli-lilly-and-company-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"LLY"},{"@type":"PropertyValue","propertyID":"ISIN","value":"US5324571083"},{"@type":"PropertyValue","propertyID":"WKN","value":"858560"}],"address":{"@type":"PostalAddress","addressCountry":"US"},"subjectOf":{"@type":"Dataset","name":"Eli Lilly and Company — key figures","url":"https://alysly.com/markets/stocks/eli-lilly-and-company/","description":"Eli Lilly and Company (LLY). Revenue $65.2bn, net margin 31.7% (FY ended Dec 2025). ISIN US5324571083 · WKN 858560.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":22},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":16.3967},{"@type":"PropertyValue","name":"YTD return (%)","value":31.9},{"@type":"PropertyValue","name":"1-year return (%)","value":67.9},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Revenue (USD)","unitText":"USD","value":65179000000.0},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":20640000000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":112476000000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":26535000000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":22.95},{"@type":"PropertyValue","name":"Net margin (%)","value":31.7},{"@type":"PropertyValue","name":"Return on equity (%)","value":77.8},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-31"}],"temporalCoverage":"2024-07-11/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}